Results 11 to 20 of about 24,539 (235)

HEALTH-RELATED QUALITY OF LIFE OF PREGNANT WOMEN WITH HEARTBURN AND REGURGITATION

Arquivos de Gastroenterologia, 2015
Background Heartburn and regurgitation frequently occur in the third trimester of pregnancy, but their impact on quality of life has not been thoroughly investigated.
Valesca DALL'ALBA, Sidia Maria CALLEGARI-JACQUES, Cláudio KRAHE, Juliana Paula BRUCH, Bruna Cherubini ALVES, Sérgio Gabriel Silva de BARROS   +5 more
doaj   +2 more sources

The importance of functional diagnostics in determining the cause of antisecretary therapy inefficiency in a patient with heartburn: clinical observation

Медицинский совет, 2021
One of the main symptoms of gastroesophageal reflux disease is heartburn, for the relief of which proton pump inhibitors are traditionally prescribed. However, there are frequent cases of heartburn, refractory to antisecretory therapy, when there is no ...
E. V. Barkalova, D. N. Andreev, M. A. Ovsepian   +2 more
doaj   +3 more sources

Efficacy of application of alginates in treatment of a heartburn at pregnant women

Российский журнал гастроэнтерологии, гепатологии, колопроктологии, 2009
Aim of investigation. To estimate frequency, factors of development of heartburn at pregnant women, to determine approach of pharmaceutical treatment by alginates.Material and methods.
E. V. Onuchina, E. A. Gorobets, A. A. Rozhansky, V. V. Tsukanov   +3 more
doaj   +1 more source

First‐Line Osimertinib in Patients with EGFR‐Mutant Advanced Non‐Small Cell Lung Cancer: Outcome and Safety in the Real World: FLOWER Study

The Oncologist, EarlyView., 2021
Abstract Lessons Learned Osimertinib has confirmed effectiveness in this real‐world population of patients with EGFR‐mutant advanced non‐small cell lung cancer. Thromboembolic events occur more frequently than previously reported, suggesting a thrombotic diathesis that requires further investigation. Patients with at least three metastatic sites, brain
Martina Lorenzi, Alessandra Ferro, Fabiana Cecere, Daniela Scattolin, Alessandro Del Conte, Alessandro Follador, Sara Pilotto, Valentina Polo, Mariacarmela Santarpia, Rita Chiari, Alberto Pavan, Alessandro Dal Maso, Valentina Da Ros, Giada Targato, Sabrina Vari, Stefano Indraccolo, Fiorella Calabrese, Stefano Frega, Laura Bonanno, Pier Franco Conte, Valentina Guarneri, Giulia Pasello   +21 more
wiley   +1 more source

The effect of adding duloxetine to lansoprazole on symptom and quality of life improvement in patients with gastroesophageal reflux diseases: A randomized double-blind clinical trial

Journal of Research in Medical Sciences, 2021
Background: Gastroesophageal reflux disease (GERD) is a common upper gastrointestinal disorder with a negative impact on the quality of life. This study was aimed to assess the effect of adding duloxetine to lansoprazole on the symptom and quality of ...
Marjan Mokhtare, Arezoo Chaharmahali, Mansour Bahardoust, Atefeh Ghanbari, Arash Sarveazad, Roozbeh Naghshin, Farbod Abbaskhanidavanloo   +6 more
doaj   +1 more source

Evaluation of the Efficacy and Safety of Vonoprazan in Patients with Nonerosive Gastroesophageal Reflux Disease: A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study

Current Therapeutic Research, 2016
Background: For many patients, current treatments do not adequately resolve heartburn in nonerosive reflux disease (NERD). Objective: To compare vonoprazan and placebo with respect to the frequency and severity of heartburn in patients with NERD. Methods:
Yoshikazu Kinoshita, MD, PhD, Yuuichi Sakurai, MPharm, Madoka Shiino, MPharm, Kentaro Kudou, MS, Akira Nishimura, BSc, MBA, Takuya Miyagi, MD, PhD, Katsuhiko Iwakiri, MD, PhD, Eiji Umegaki, MD, PhD, Kiyoshi Ashida, MD, PhD   +8 more
doaj   +1 more source

DYSPEPSIA AND HEARTBURN

Rheumatic Disease Clinics of North America, 1999
Dyspepsia and heartburn are the two cardinal symptoms of foregut dysfunction. When confronting such a problem, that physician must first learn to discern between the two, because treatment can be quite different for the conditions presenting with these symptoms.
N A, Ahmad, D C, Metz
openaire   +2 more sources

Heartburn of pregnancy

Gastroenterology, 1977
Lower esophageal sphincter pressure, basal gastric pH, fasting plasma gastrin, and plasma concentrations of estrone, estradiol, and progesterone were measured in pregnant volunteers at 12, 24, and 36 weeks of gestation, and again at 1 to 4 weeks postpartum.
D H, Van Thiel, J S, Gavaler, S N, Joshi, R K, Sara, J, Stremple   +4 more
openaire   +2 more sources

Treatment of Gastrointestinal Disorders—Plants and Potential Mechanisms of Action of Their Constituents

Molecules, 2022
The worldwide prevalence of gastrointestinal diseases is about 40%, with standard pharmacotherapy being long-lasting and economically challenging. Of the dozens of diseases listed by the Rome IV Foundation criteria, for five of them (heartburn, dyspepsia,
Szilvia Czigle, Silvia Bittner Fialová, Jaroslav Tóth, Pavel Mučaji, Milan Nagy, on behalf of the OEMONOM   +5 more
doaj   +1 more source

Gastroesophageal reflux disease: risk factors, current possibilities of diagnosis and treatment optimisation

Медицинский совет, 2022
Gastroesophageal reflux disease (GERD) is one of the most common causes of health care seeking at the primary care level in many countries. At an epidemiological level, GERD has been shown to be associated with a number of risk factors: obesity, tobacco ...
I. V. Maev, D. N. Andreev, M. A. Ovsepyan, E. V. Barkalova   +3 more
doaj   +1 more source